620 related articles for article (PubMed ID: 3005353)
1. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
[TBL] [Abstract][Full Text] [Related]
2. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
[TBL] [Abstract][Full Text] [Related]
3. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
[TBL] [Abstract][Full Text] [Related]
4. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
5. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease.
Nieman LK; Cutler GB; Oldfield EH; Loriaux DL; Chrousos GP
J Clin Endocrinol Metab; 1989 Jul; 69(1):165-9. PubMed ID: 2543689
[TBL] [Abstract][Full Text] [Related]
6. Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.
Pieters GF; Smals AG; Goverde HJ; Pesman GJ; Meyer E; Kloppenborg PW
J Clin Endocrinol Metab; 1982 Dec; 55(6):1188-97. PubMed ID: 6290524
[TBL] [Abstract][Full Text] [Related]
7. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[TBL] [Abstract][Full Text] [Related]
8. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal.
Pecori Giraldi F; Invitti C; Cavagnini F;
Clin Endocrinol (Oxf); 2001 May; 54(5):601-7. PubMed ID: 11380490
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing's disease.
Pieters GF; Hermus AR; Meijer E; Smals AG; Kloppenborg PW
J Clin Endocrinol Metab; 1989 Dec; 69(6):1122-6. PubMed ID: 2555381
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
[TBL] [Abstract][Full Text] [Related]
11. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
[TBL] [Abstract][Full Text] [Related]
13. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
Watanobe H; Tamura T
J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
[TBL] [Abstract][Full Text] [Related]
14. Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's disease.
Schrell U; Fahlbusch R; Buchfelder M; Riedl S; Stalla GK; Müller OA
J Clin Endocrinol Metab; 1987 Jun; 64(6):1150-9. PubMed ID: 3033006
[TBL] [Abstract][Full Text] [Related]
15. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
[TBL] [Abstract][Full Text] [Related]
16. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
[TBL] [Abstract][Full Text] [Related]
17. CRH in Cushing's syndrome.
Müller OA; Stalla GK; von Werder K
Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
[TBL] [Abstract][Full Text] [Related]
18. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
[TBL] [Abstract][Full Text] [Related]
19. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Newell-Price J; Morris DG; Drake WM; Korbonits M; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2002 Apr; 87(4):1640-5. PubMed ID: 11932295
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]